Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 1, 2014, Pages 340-347

  Yang, Feng Qiang ^a   Huang, Jian Hua ^a   Liu, Min ^a   Yang, Feng Ping ^a   Li, Wei ^a   Wang, Guang Chun ^a   Che, Jian Ping ^a   Zheng, Jun Hua ^a,b  

^a TONGJI UNIVERSITY   (China)

^b Xinjiang Province   (China)

Author keywords

Argonaute 2; Immunohistochemical; Prognosis; Urothelial carcinoma of bladder

Indexed keywords

ARGONAUTE 2 PROTEIN; ARGONAUTE PROTEIN; EIF2C2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMICAL; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; UPREGULATION; UROTHELIAL CARCINOMA OF BLADDER; WESTERN BLOTTING;

ARGONAUTE 2; IMMUNOHISTOCHEMICAL; PROGNOSIS; UROTHELIAL CARCINOMA OF BLADDER;

ADULT; AGED; ARGONAUTE PROTEINS; BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 84891769499     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Liou LS. Urothelial cancer biomarkers for detection and surveillance. Urology 2006; 67: 25-33; discussion 33-24.
2. Smaldone MC, Jacobs BL, Smaldone AM and Hrebinko RL Jr. Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma. Urology 2008; 72: 613-616.
3. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D and Skinner DG. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-675.
4. Hautmann RE, Gschwend JE, de Petriconi RC, Kron M and Volkmer BG. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 2006; 176: 486-492; discussion 491-482.
5. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
6. Lima RT, Busacca S, Almeida GM, Gaudino G, Fennell DA and Vasconcelos MH. MicroRNA regulation of core apoptosis pathways in cancer. Eur J Cancer 2011; 47: 163-174.
7. Kim WC and Lee CH. The role of mammalian ribonucleases (RNases) in cancer. Biochim Biophys Acta 2009; 1796: 99-113.
8. Zha X, Xia Q and Adam Yuan Y. Structural insights into small RNA sorting and mRNA target binding by Arabidopsis Argonaute Mid domains. FEBS Lett 2012; 586: 3200-7.
9. Juvvuna PK, Khandelia P, Lee LM and Makeyev EV. Argonaute identity defines the length of mature mammalian microRNAs. Nucleic Acids Res 2012; 40: 6808-6820.
10. Meister G. Argonaute proteins: functional insights and emerging roles. Nat Rev Genet 2013; 14: 447-459
11. O'Carroll D, Mecklenbrauker I, Das PP, Santana A, Koenig U, Enright AJ, Miska EA and Tarakhovsky A. A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev 2007; 21: 1999-2004.
12. Cheng N, Li Y and Han ZG. Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma. Hepatology 2013; 57: 1906-1918.
13. Zhang J, Fan XS, Wang CX, Liu B, Li Q and Zhou XJ. Up-regulation of Ago2 expression in gastric carcinoma. Med Oncol 2013; 30: 628.
14. Li W, Liu M, Feng Y, Xu YF, Che JP, Wang GC, Zheng JH, Gao HJ. Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma. Int J Clin Exp Pathol 2013; 6: 1086-94.
15. Greene FL, Page DL, Fleming ID, April F, Balch CM, Haller DG, Monica M. American Joint Committee on Cancer (AJCC) staging manual. 6th edition. Philadelphia: Springer; 2002.
16. Lynch HT and Smyrk TC. Identifying hereditary nonpolyposis colorectal cancer. N Engl J Med 1998; 338: 1537-1538.
17. Plummer PN, Freeman R, Taft RJ, Vider J, Sax M, Umer BA, Gao D, Johns C, Mattick JS, Wilton SD, Ferro V, McMillan NA, Swarbrick A, Mittal V and Mellick AS. MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells. Cancer Res 2013; 73: 341-352.
18. Farazi TA, Hoell JI, Morozov P and Tuschl T. MicroRNAs in Human Cancer. In: editors. MicroRNA Cancer Regulation. Springer; 2013. pp: 1-20.
19. Chen S, Chahar HS, Abraham S, Wu H, Pierson TC, Wang XA and Manjunath N. Ago-2-mediated slicer activity is essential for anti-flaviviral efficacy of RNAi. PLoS One 2011; 6: e27551.
20. Diederichs S and Haber DA. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 2007; 131: 1097-1108.
21. Chen Z, Lai TC, Jan YH, Lin FM, Wang WC, Xiao H, Wang YT, Sun W, Cui X, Li YS, Fang T, Zhao H, Padmanabhan C, Sun R, Wang DL, Jin H, Chau GY, Huang HD, Hsiao M and Shyy JY. Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis. J Clin Invest 2013; 123: 1057-1067.